About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Careers
Technology
DNA Technology
Poloxamer Delivery System
Vaxfectin
®
Adjuvant
Products
Pipeline
VCL-HB01 Therapeutic HSV-2 Vaccine
VL-2397 Antifungal
Other Products
Apex
®
-IHN
Dengue Vaccine
ONCEPT
®
Clinical Trials
Overview & Active Programs
Compassionate Use
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Contact Us
Contact Info
Directions to Vical
Careers
NASDAQ | VICL
:
1.47
-0.07
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Home
/
Investors
/
Events & Presentations
/
Event Details
Credit Suisse 2012 Healthcare Conference
November 14, 2012
Time: 02:30 PM MST
View the Webcast
View the Press Release
View the Related Document
About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Careers
Technology
DNA Technology
Poloxamer Delivery System
Vaxfectin
®
Adjuvant
Products
Pipeline
VCL-HB01 Therapeutic HSV-2 Vaccine
VL-2397 Antifungal
Other Products
Apex
®
-IHN
Dengue Vaccine
ONCEPT
®
Clinical Trials
Overview & Active Programs
Compassionate Use
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Contact Us
Contact Info
Directions to Vical
Careers
CONNECT WITH US
RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube
© 2017 Vical Inc.
Privacy Policy
Terms of Use
Site Map
P. 858 646 1100
10390 Pacific Center Court, San Diego, California 92121
Designed by
Mentus
Powered By Q4 Inc.
5.4.1.6
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.